Abstract: The present invention relates to a method for determining a personalised docosallexaenoic acid (DHA) supplementation dose to be taken by a mother to meet the DHA requirements of the mother's infant.

Abstract: Synthetic nutritional formulations, particularly milk based compositions, for infants and children are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Abstract: Synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks, vary according to gender and the age of the infant or young child. The compositions have been designed to ensure balanced growth and to prevent obesity in in-fancy and later in life.

Abstract: The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child, younger or older than three months. The invention further relates to administration of these compositions for promoting the healthy establishment of cognitive function in infant boys and girls and in young boys and girls up to the age of thirty-six months.

Abstract: The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Abstract: Embodiments of the present disclosure relate to a chassis for a two-wheeler. The chassis includes a first downtube and a second downtube and a battery mounting system. The battery mounting system includes a movable battery housing configured to house a battery under a seat of the two-wheeler and move between a closed position and an open position, at least two support members configured to support the movable battery housing, and at least one pivot hinge coupled to a front side of the movable battery housing and supporting the movable battery housing. The at least two support members and the at least one pivot hinge are configured to enable an angular movement of the movable battery housing with respect to a seat axis between the open position and the closed position, thereby enabling replacement of the battery located under the seat of the two-wheeler, while maintaining a closed seat position of the seat.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising Lutein in concentrations reflecting those found in human milk produced for infants of the same age (at the corresponding lactation stage), and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions comprising lutein in concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding age/stage of lactation, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions for female or male infants of 1 to 2 months of age wherein, the concentration of arginine is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions for infants 1 to 2 months of age or up to 1 month of age wherein, the concentration of lysine is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions for infants up to 1 month of age contain a caseins content adapted based on that found in human milk produced for an infant of the same gender and age. The compositions can be used in a method of treating, protecting or mitigating sub-optimal growth and development of an infant up to 1 month of age.

Abstract: A nutritional composition contains Fut2-dependent oligosaccharides for promoting brain growth and development in infants in the very early postnatal period. The nutritional composition contains Fut2-dependent oligosaccharides and Lacto-N-neotetraose and is specifically for use in promoting brain catch-up growth in preterm infants or infants with low-birth weight. A kit can include at least two of these nutritional compositions.

Abstract: This invention relates to an age-tailored nutritional composition system comprising an adaptive level of human milk oligosaccharides (HMOS) and a method for preparing said system. The age-tailored nutritional composition system comprises at least two nutritional compositions for infants of a certain age, which differ from each other in the amount of HMOs present therein. It is specifically adapted to the evolving nutritional needs of infants from their birth to the end of the breast feeding period.

Abstract: Gender specific synthetic nutritional compositions comprising lycopene in concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding stage of lactation, and nutritional systems comprising them.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising Lycopene in concentrations reflecting those found in human milk produced for infants of the same age, and nutritional systems comprising them.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising cholesterol in concentrations reflecting those found in human milk produced for infants of the same specific ages, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions comprising cholesterolin concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding stage of lactation, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions comprising gamma tocopherol in concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding stage of lactation, and nutritional systems comprising them.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising gamma tocopherol in concentrations reflecting those found in human milk produced for infants at a corresponding lactation stage, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions for infants 4 to 8 months of age, 1 to 2 months of age, or up to 1 month of age. The concentration of methionine is adapted based on that found in human milk produced for an infant of the same gender and age. Also provided are nutritional systems including the gender specific synthetic nutritional compositions, and methods of using the compositions and the systems.